Moneycontrol PRO

you are here: HomeNewsBusinessCNBC-TV18 CommentsUSFDA opposes Mylan's injunction on Ranbaxy's Lipitor

SHOW NAMES

Trending Topics

Sensex Live Urban Company IPO GMP Amanta Healthcare share price RailTel Share Price Goel Construction Company IPO

business

USFDA opposes Mylan's injunction on Ranbaxy's Lipitor

Ranbaxy is in focus again as the US Foods and Drugs Administration (USFDA) has filed an opposition to US-based pharmaceutical firm Mylan Inc's preliminary injunction on the launch of Ranbaxy's cholesterol treatment drug, which is a generic version of Pfizer's Lipitor, reports CNBC-TV18's Ekta Batra quoting sources.

first published: Apr 7, 2011 11:02 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347